Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients
- 30 April 1996
- journal article
- Published by Elsevier
- Vol. 34 (4) , 626-631
- https://doi.org/10.1016/s0190-9622(96)80062-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Why does a higher repseonse rate to chemotherapy correlate poorly with improved survival?Zeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatmentCA: A Cancer Journal for Clinicians, 1993
- Thymopentin in Sezary SyndromeJNCI Journal of the National Cancer Institute, 1992
- Subcutaneous administration of methotrexateJournal of the American Academy of Dermatology, 1992
- Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patientsJournal of the American Academy of Dermatology, 1990
- Sézary syndrome: Diagnosis, prognosis, and critical review of treatment optionsJournal of the American Academy of Dermatology, 1990
- Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary SyndromeAnnals of Internal Medicine, 1988
- Methotrexate in psoriasis: Revised guidelinesJournal of the American Academy of Dermatology, 1988
- Reporting outcomes in Hodgkin's disease and lymphoma.Journal of Clinical Oncology, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958